Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerBilling CodesMicrobiology Culture and Typing ProceduresCPT cpt-87106-yeast-isolate-species-identification
    Ask Trek AI about this page

    CPT 87106: Yeast Identification to Species Level

    CPT code 87106 describes additional laboratory testing performed by a lab analyst to definitively identify a presumptively identified yeast isolate, typically involving organism-level (for example, species) identification; service type: microbiology identification testing, typical site of service: clinical laboratory or hospital laboratory.

    For related coverage guidance, see recent payer policy updates: Truvada (Emtricitabine and Tenofovir Disoproxil Fumarate) for HIV Prevention and Treatment, HIV/AIDS Pharmacologic Prevention and Treatment, Long-Acting Injectable Antiretroviral Agents for HIV.

    Customize your policy alerts

    Sign up for cpt 87106 policy alerts

    Get alerted when payer policies referencing 87106 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Table of contents

    Progress1 / 7

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical & Coding Specifications

    Clinical Context

    A patient presents to an outpatient infectious disease clinic with persistent funguria and recurrent urinary symptoms after initial empiric antimicrobial therapy. Urine culture grows a presumptive yeast isolate on primary media. The laboratory technologist performs initial identification (e.g., morphology, germ tube test) and forwards the isolate to the microbiology laboratory’s mycology bench for definitive species-level identification. The lab analyst conducts additional phenotypic testing (biochemical panels, carbohydrate assimilation), MALDI-TOF mass spectrometry, or molecular methods to identify the yeast to species. Results are reported to the ordering clinician to guide antifungal selection (for example, differentiating Candida albicans from Candida glabrata). Typical workflow steps: specimen receipt and verification, subculture and isolation, presumptive identification, performance of 87106 level definitive identification tests, review and validation by a laboratory director, and result reporting in the electronic medical record. Typical site of service is an outpatient clinical microbiology laboratory, hospital laboratory, or reference laboratory. Common patient scenarios include persistent or recurrent candiduria, bloodstream infection surveillance isolates forwarded for specialty ID lab work, or isolates from sterile sites requiring species-level identification for targeted therapy.

    Related CPT Codes

    CPT CodeDescriptionRelationship to This Procedure
    87070Culture, bacterial; any other source, with isolation and presumptive identification of bacterial coloniesPerformed prior to 87106 when cultures from clinical specimens produce isolates that require presumptive identification before species-level yeast testing.
    87140Culture, fungal, pathogenic; any other source, direct examination and presumptive identificationOften performed as the initial fungal culture; positive fungal growth may then be forwarded for definitive identification by 87106.
    88348Surgical pathology, microbiology consultative services (interpretation of culture or organism)May be used when pathology consults on microbiology results that include species-level identification implications.
    87481Infectious agent antigen detection by immunoassay technique, Streptococcus, group A; qualitative or semiquantitative, multiple-step methodRepresents examples of organism-specific testing; organism-specific assays may complement species identification workflows.
    87802Infectious agent antigen detection by immunoassay technique, multiple agents; qualitative or semiquantitativeAntigen or rapid tests that may be performed alongside culture-based identification in diagnostic workflows.

    Related Modifiers

    5 rows

    ModifierDescriptionWhen to Use
    26Modifier 26 (Professional Component) identifies and bills only the professional portion of a split service — the physician’s interpretation, report, and medical judgment — when the technical…- Use CPT Modifier -26 when you are billing only the professional component (PC) of a split‑bill eligible service—i.e., you performed the physician interpretation, medical judgment and prepared a…
    59Modifier 59 indicates a distinct procedural service when two procedures that are not normally billed together are clinically and procedurally separate. The CPT definition (as reiterated by CMS)…- Use modifier -59 to report a distinct procedural service when documentation supports that the procedure reported is not normally billed together with another service on the same day because of a…
    90Modifier ‑90 (Reference/Outside Laboratory) indicates that a laboratory test was performed by an entity other than the treating or reporting provider. The American Medical Association defines…- Use CPT modifier -90 when a laboratory test is performed by an outside/reference laboratory (an entity other than the treating or reporting physician or qualified professional) and the claim needs…
    91Modifier 91 — “Repeat Clinical Diagnostic Laboratory Test” — is appended when the exact same CPT laboratory test is performed more than once for the same patient on the same day because serial,…- Use modifier 91 when the exact same CPT laboratory test is performed more than once on the same patient on the same date because serial or repeated testing is medically necessary to monitor…
    1PModifier 1P is a Category II performance measure exclusion modifier used to indicate that a patient’s medical condition prevented performance of the action specified by a Category II quality measure…- Use modifier 1P only with Category II (quality reporting) codes when the specific measure’s reporting instructions explicitly allow a medical-reason exclusion; it marks the patient as medically…

    Related Provider Taxonomies

    8 rows

    Taxonomy Code
    207RG0300X
    207K00000X
    2080P0207X
    208D00000X
    202K00000X
    146E00000X
    1835N0905X
    385H00000X

    Related ICD-10-CM Codes

    22 rows

    ICD-10-CM CodeDescription
    A54.02Gonococcal vulvovaginitis, unspecified
    A54.85Gonococcal peritonitis
    B37.0Candidal stomatitis
    B37.1Pulmonary candidiasis
    B37.2Candidiasis of skin and nail
    B37.5Candidal meningitis
    B37.6Candidal endocarditis
    B37.9Candidiasis, unspecified
    B95.1Streptococcus, group B, as the cause of diseases classified elsewhere
    B95.2Enterococcus as the cause of diseases classified elsewhere

    Showing 1–10 of 22

    Related Payer Policy Updates

    Specialty: Infectious Disease1 / 3

    10 rows

    PolicyPayerEffective Date
    Truvada (Emtricitabine and Tenofovir Disoproxil Fumarate) for HIV Prevention and Treatmentpremerabluecrossofwashington2026-10-01
    HIV/AIDS Pharmacologic Prevention and Treatmentpremerabluecrossofwashington2026-10-01
    Long-Acting Injectable Antiretroviral Agents for HIVColorado Rocky Mountain Health Plans2026-10-01
    B-Hemolytic Streptococcus TestingOscar Health2026-10-01
    Human Immunodeficiency Virus (HIV) — Coverage Criteria for Testing and Resistance AssaysOscar Health2026-10-01
    Hepatitis Testing (A, B, C, D) Coverage CriteriaOscar Health2026-10-01
    Lyme Disease Testing Coverage CriteriaOscar Health2026-10-01
    Pathogen Panel TestingOscar Health2026-10-01
    Diagnostic Testing of Common Sexually Transmitted InfectionsOscar Health2026-10-01
    Testing for Vector-Borne InfectionsOscar Health2026-10-01

    Related Codes

    87086-CULTURE-BACTERIAL-QUANTITATIVE-COLONY-COUNT

    CPT 87086: Urine Culture with Quantitative Colony Count

    CPT-87040-BLOOD-CULTURE-ISOLATION-PRESUMPTIVE-IDENTIFICATION

    CPT 87040: Blood Bacterial Culture with Isolation and Presumptive ID

    CPT-87045-AEROBIC-BACTERIAL-STOOL-CULTURE-SALMONELLA-SHIGELLA

    CPT 87045: Aerobic Bacterial Stool Culture for Salmonella/Shigella

    CPT-87046-AEROBIC-BACTERIAL-STOOL-CULTURE-PRESUMPTIVE-ID-NON-SALMONELLA-SHIGELLA

    CPT 87046: Aerobic Bacterial Stool Culture, Presumptive ID (non-Salmonella/Shigella)

    CPT-87070-AEROBIC-CULTURE-ISOLATION-PRESUMPTIVE-IDENTIFICATION

    CPT 87070: Aerobic Culture with Isolation and Presumptive Identification

    CPT-87071-AEROBIC-QUANTITATIVE-BACTERIAL-CULTURE-NON-URINE-BLOOD-STOOL

    CPT 87071: Quantitative Aerobic Bacterial Culture, Non-urine/blood/stool

    CPT-87073-ANAEROBIC-CULTURE-NONBLOOD-NONURINE-NONSTOOL

    CPT 87073: Anaerobic Culture, Non-Urine/Blood/Stool

    CPT-87075-ANAEROBIC-CULTURE-IDENTIFICATION-NON-BLOOD-SPECIMEN

    CPT 87075: Anaerobic Culture and Bacterial Identification (Nonblood)

    CPT-87076-ANAEROBIC-ISOLATE-DEFINITIVE-IDENTIFICATION

    CPT 87076: Anaerobic Isolate Identification to Species Level

    CPT-87077-DEFINITIVE-IDENTIFICATION-AEROBIC-ISOLATE

    CPT 87077: Definitive Identification of Aerobic Isolate

    Showing 1–10 of 30

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.